Hexaware Technologies Announces Board Changes with New Independent Director Appointment
Hexaware Technologies has implemented comprehensive board changes effective February 23, 2026, appointing Alok Chandra Misra as Additional Non-Executive Independent Director for a 3-year term while accepting the resignation of Vivek Sharma due to professional commitments. The company has reconstituted multiple committees including Audit, Nomination & Remuneration, Risk Management, ESG, and Cybersecurity committees with Mr. Misra's inclusion, and expanded Shantanu Baruah's role to include North America Hunting Head responsibilities alongside his existing Healthcare & Insurance vertical leadership position.

*this image is generated using AI for illustrative purposes only.
Hexaware Technologies Limited has announced comprehensive changes to its Board of Directors and committee structure, effective February 23, 2026. The IT services company disclosed these developments in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
New Independent Director Appointment
The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Mr. Alok Chandra Misra (DIN: 01542028) as Additional Director in the capacity of Non-Executive Independent Director. The appointment details are structured as follows:
| Parameter: | Details |
|---|---|
| Term Duration: | 3 years |
| Commencement Date: | February 23, 2026 |
| End Date: | February 22, 2029 |
| Approval Required: | Shareholders of the Company |
| Debarment Status: | Not debarred by SEBI or other authorities |
Mr. Misra brings extensive experience to the role, having recently co-founded Guvrn as India's first curated board network connecting independent directors with companies seeking improved governance. Until June 2024, he served as Operating Partner and Chief Operating Officer of India at General Atlantic, a leading global growth equity investment firm. His previous experience includes serving as Group Chief Financial Officer with WNS Group and Mphasis BFL Group, along with roles at ITC Limited and PwC. He is a Fellow member of the Institute of Chartered Accountants of India and holds an honours degree in commerce from Calcutta University.
Director Resignation
Mr. Vivek Sharma (DIN: 10741746) tendered his resignation as Independent Director, effective from close of business hours on February 23, 2026, citing other professional commitments as the reason. His departure also results in cessation from his roles as member of the Stakeholders Relationship Committee and Corporate Social Responsibility Committee. In his resignation letter, Mr. Sharma confirmed no other material reasons exist for his resignation beyond those mentioned.
Committee Reconstitution
The Board approved Mr. Alok Chandra Misra's appointment to multiple committees, enhancing the governance structure:
| Committee: | New Composition |
|---|---|
| Audit Committee: | Milind Sarwate (Chairman), Sukanya Kripalu, Alok Misra, Kapil Modi |
| Nomination & Remuneration Committee: | Milind Sarwate (Chairman), Sukanya Kripalu, Joseph McLaren Quinlan, Alok Misra, Kapil Modi |
| Risk Management Committee: | Joseph McLaren Quinlan (Chairman), Milind Sarwate, Alok Misra, Kapil Modi, Shawn Devilla |
| Environmental, Social & Governance Committee: | Milind Sarwate (Chairman), Sukanya Kripalu, Alok Misra, Neeraj Bharadwaj |
| Cybersecurity Committee: | Lucia Soares (Chairperson), Milind Sarwate, Joseph McLaren Quinlan, Alok Misra |
Senior Management Role Expansion
The Board also approved the appointment of Mr. Shantanu Baruah for an additional role as North America – Hunting Head, effective February 23, 2026, while retaining his position as President & Global Head – Healthcare & Insurance Vertical. Mr. Baruah brings over 25 years of experience in the healthcare and life sciences industry, with a strong track record in building global teams and leading client transformations. He previously served as Executive Vice President at HCL Tech, leading the Healthcare business in North America, and is a published author on healthcare technology topics.
Regulatory Compliance
All appointments and changes comply with SEBI regulations and have been disclosed pursuant to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company confirmed that detailed annexures containing comprehensive information about the appointments and resignations have been submitted to the stock exchanges and will be hosted on the company's website.
Historical Stock Returns for Hexaware Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.30% | -10.30% | -29.56% | -34.90% | -36.88% | -33.94% |


































